Friday, 21 January 2022

 

 

LATEST NEWS Health services are continuously improving during the tenure of the present state government : Anil Vij Jai Ram Thakur launches Apna Kangra App and Apna Kangra hamper at Dharamshala AAP’s CM candidate Bhagwant Mann to contest from Dhuri Lehra Vikas Manch President Advocate Barinder Kumar Goyal joins AAP Medical reimbursement facility to be provided to all retired employees of HPBSE : Jai Ram Thakur Rahul Gandhi aide holds Twitter poll for Punjab CM, Channi comes first FII outflows plunge equity indices; Sensex, Nifty settle 1% down Post-Covid fatigue is a real thing : Swara Bhaskar Aanand L. Rai: 'Atrangi Re' is fiction, doesn't offer solution to mental illness IED blast in busy Lahore market leaves two dead, several injured Shoot to Thrill: Aparshakti Khurana excited to grab the gun again Australia rise to top of ICC Test rankings, India slip down to third spot Fra Fee joins 'Beauty and the Beast' prequel series Rohit Sharma, Rishabh Pant and Ravichandran Ashwin included in ICC Men's Test Team of the Year Malayalam actress Anna Ben tests positive for Covid Lakshmi Manchu urges Telangana govt to institutionalise digital education 'Gehraiyaan': Deepika, Siddhant, Ananya get tangled in complex web of relationships Mithali Raj, Jhulan Goswami named in ICC Women's ODI Team of the Year Hrithik Roshan shares glimpse of his 68-year-old mother's intense workout Akhilesh Yadav to revive Yash Bharti awards if voted to power No Indian in ICC Men's ODI Team of the Year captained by Babar Azam

 

WHO advises against use of convalescent plasma for Covid treatment

Omicron variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Oxygen supply , Liquid Medical Oxygen , Oximeter

Web Admin

Web Admin

5 Dariya News

Geneva , 07 Dec 2021

Convalescent plasma shows no improvement in survival and other important measures and is not recommended for patients with Covid-19, according to a study released on Tuesday by the World Health Organization (WHO).Covid-19 convalescent plasma, also known as "survivor's plasma", is transfusion of blood plasma from patients who have recovered from Covid-19. Last year, the US Food and Drug Administration (FDA) issued an emergency use authorisation to allow use of convalescent plasma in hospitalised patients with Covid-19.A WHO Guideline Development Group of international experts in The BMJ wrote that despite its initial promise, current evidence shows that it does not improve survival nor reduce the need for mechanical ventilation, and it is costly and time-consuming to administer.The WHO made a strong recommendation against the use of convalescent plasma in patients with non-severe illness, and in patients with severe and critical illness, except in the context of a randomised controlled trial (RCT).The recommendations are based on evidence from 16 trials involving 16,236 patients with non-severe, severe, and critical Covid infection.

And although convalescent plasma should not be used routinely in any patients, regardless of how severely ill they are, the panel acknowledged that there was sufficient uncertainty in patients with severe and critical illness to warrant continuation of RCTs.The guidance adds to previous recommendations for the use of interleukin-6 receptor blockers and systemic corticosteroids for patients with severe or critical Covid-19; conditional recommendations for the use of neutralising monoclonal antibodies in selected patients and against the use of ivermectin and hydroxychloroquine in patients with covid-19 regardless of disease severity.The therapy involves transfusing plasma, the pale yellow liquid in blood that is rich in antibodies, from people who have recovered from Covid-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalised with the viral infection. The goal is to accelerate their disease-fighting response.In August, a study led by the US National Institutes of Health (NIH) also stated that early administration of convalescent plasma does not prevent disease progression in a high-risk group of Covid-19 patients.In May, the Indian Council of Medical Research (ICMR) dropped the plasma therapy as Covid-19 treatment, citing no significant benefit.

 

Tags: Omicron variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Oxygen supply , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD